Literature DB >> 1636186

Combined magnetic resonance imaging and proton magnetic resonance spectroscopy of patients with acute stroke.

S R Felber1, F T Aichner, R Sauter, F Gerstenbrand.   

Abstract

BACKGROUND AND
PURPOSE: The prospect for a therapeutic window for treatment of ischemic stroke encourages the noninvasive investigation of metabolic changes in acute ischemia. Recently, localized proton spectroscopy became available at 1.5-T magnetic resonance systems. In this study we evaluated the usefulness of combined magnetic resonance imaging and spectroscopy on the diagnosis of acute and chronic infarctions.
METHODS: Combined magnetic resonance imaging and spectroscopy investigations were carried out with a 1.5-T system in 16 volunteers, eight patients with chronic infarction (greater than 8 months), and 10 patients with acute ischemic stroke (less than 8 hours). We used a stimulated echo sequence to acquire localized spectra from image-guided volumes of interest (16-27 ml).
RESULTS: There were no significant interindividual differences of choline, creatine, phosphocreatine, and N-acetyl aspartate resonances in the spectra from volunteers. In chronic infarctions, N-acetyl aspartate was decreased in relation to choline. Acute ischemic infarctions were characterized by decreased N-acetyl aspartate resonances and elevation of lactate.
CONCLUSIONS: The study demonstrates the feasibility of proton spectroscopy in stroke patients. Metabolic alterations in ischemic tissue can be monitored and can distinguish acute from chronic lesions.

Entities:  

Mesh:

Year:  1992        PMID: 1636186     DOI: 10.1161/01.str.23.8.1106

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  10 in total

1.  Prognostic significance of metabolic changes detected by proton magnetic resonance spectroscopy in ischaemic stroke.

Authors:  F Federico; I L Simone; C Conte; V Lucivero; P Giannini; M Liguori; E Picciola; C Tortorella
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

Review 2.  [Diagnosis of stroke--an update].

Authors:  Franz T Aichner
Journal:  Wien Med Wochenschr       Date:  2003

Review 3.  Nuclear magnetic resonance spectroscopy. Principles and applications in neuroophthalmology.

Authors:  A Ettl; C Fischer-Klein; A Chemelli; A Daxer; S Felber
Journal:  Int Ophthalmol       Date:  1994       Impact factor: 2.031

4.  Association between baseline peri-infarct magnetic resonance spectroscopy and regional white matter atrophy after stroke.

Authors:  Nawaf Yassi; Bruce C V Campbell; Bradford A Moffat; Christopher Steward; Leonid Churilov; Mark W Parsons; Geoffrey A Donnan; Patricia M Desmond; Stephen M Davis; Andrew Bivard
Journal:  Neuroradiology       Date:  2015-09-16       Impact factor: 2.804

5.  Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy.

Authors:  F Federico; I L Simone; V Lucivero; M De Mari; P Giannini; G Iliceto; D M Mezzapesa; P Lamberti
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-03       Impact factor: 10.154

6.  Neuronal metabolic changes in the cortical region after subcortical infarction: a proton MR spectroscopy study.

Authors:  D W Kang; J K Roh; Y S Lee; I C Song; B W Yoon; K H Chang
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-08       Impact factor: 10.154

7.  Clinical features associated with internal carotid artery occlusion do not correlate with MRA cerebropetal flow measurements.

Authors:  K J van Everdingen; L J Kappelle; C J Klijn; W P Mali; J van Der Grond
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-03       Impact factor: 10.154

8.  Proton magnetic resonance spectroscopy in patients with ischemic stroke.

Authors:  F Federico; C Conte; I L Simone; P Giannini; M Liguori; E Picciola; C Tortorella; E Ferrari
Journal:  Ital J Neurol Sci       Date:  1994-11

Review 9.  What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy?

Authors:  J Vion-Dury; D J Meyerhoff; P J Cozzone; M W Weiner
Journal:  J Neurol       Date:  1994-05       Impact factor: 4.849

10.  Serial Cerebral Metabolic Changes in Patients With Ischemic Stroke Treated With Autologous Bone Marrow Derived Mononuclear Cells.

Authors:  Muhammad E Haque; Refaat E Gabr; Sarah D George; Seth B Boren; Farhaan S Vahidy; Xu Zhang; Octavio D Arevalo; Susan Alderman; Ponnada A Narayana; Khader M Hasan; Elliott R Friedman; Clark W Sitton; Sean I Savitz
Journal:  Front Neurol       Date:  2019-02-25       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.